Phathom Pharmaceuticals, Inc.
PHAT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001783183
No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Phathom Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 133 | 173 | +40 |
| Shares | 62.3M | 62.0M | −370.1K (−0.6%) |
| Value | $733.6M | $1.03B | +$291.9M (+39.8%) |
New holders (50)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (10)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AIGH Capital Management LLC | 429,000 | $5.05M |
| Walleye Capital LLC | 290,467 | $3.42M |
| PharVision Advisers, LLC | 30,968 | $364.5K |
| Quadrature Capital Ltd | 30,272 | $356.0K |
| Omers Administration Corp | 16,500 | $194.2K |
| Kestra Private Wealth Services, LLC | 15,500 | $182.4K |
| Quarry LP | 7,007 | $82.5K |
| Leonteq Securities AG | 4,800 | $56.5K |
| Bear Mountain Capital, Inc. | 1,000 | $14.0K |
| SBI Securities Co., Ltd. | 23 | $271 |